Skip to main content
Research examines efficacy of individualized glycemic control in diabetes

An individualized approach to glycemic control in type 2 diabetes reduced life expectancy due to an increase in complications, but patients had an increase in quality-adjusted life-years resulting from fewer hypoglycemic events and medications, compared with the uniform intensive control group, according to a study in the Annals of Internal Medicine. Researchers evaluated data from the National Health and Nutrition Examination Survey 2011 to 2012 and found that individualized control saved $13,547 per patient, compared with intensive control.

Full Story: